Digoxin - Time to take the gloves off?

International Journal of Cardiology

Volumn 164, Issue 3, 2013, Pages 365-367

  Eade, Emma ^a   Cooper, Rebecca ^a   Mitchell, Andrew R J ^b  

^a Jersey General Hospital   (United States)

^b Cancer Center   (United States)

Author keywords

Anti arrhythmic; Atrial fibrillation; Digoxin; Heart failure; Mortality

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DOBUTAMINE; FLECAINIDE; MILRINONE; PLACEBO; SPIRONOLACTONE;

ARTICLE; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; DIZZINESS; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG SAFETY; ELECTROLYTE DISTURBANCE; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PALPITATION; HEART RATE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; KIDNEY FAILURE; MORTALITY; OUTCOME ASSESSMENT; PARESTHESIA; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SINUS RHYTHM; SUDDEN DEATH; TACHYCARDIA; TORSADE DES POINTES; TREATMENT DURATION; VISUAL DISORDER; DRUG USE; LIFE EXPECTANCY; SUPRAVENTRICULAR TACHYCARDIA;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOTONIC AGENTS; DIGOXIN; HEART FAILURE; HUMANS; RISK ASSESSMENT;

EID: 84884212364     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.07.034     Document Type: Article

References (20)

1. A. Camm, P. Kirchhof, and G. Lip Guidelines for the management of atrial fibrillation - the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 2010 2369 2429
2. M. Jessup, W. Abraham, and D. Casey 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults Circulation 119 2009 1977 2016
3. W. Aronow Prevalence of appropriate and inappropriate indications for use of digoxin in older patients at the time of admission to a nursing home J Am Geriatr Soc 44 5 1996 588 590
4. K. Gjesdal, J. Feyzi, and S. Olsson Digitalis - a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data Heart 94 2 2008 191 196
5. J. Chirinos, A. Castrellon, and J. Zambrano Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation Heart Rhythm 2 5 2005 525 529
6. T. Ahern, T. Lash, H. Sørensen, and L. Pedersen Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study Breast Cancer Res 10 6 2008 R102
7. K. Chan, J. Lazarus, and R. Hakim Digoxin associates with mortality in ESRD J Am Soc Nephrol 21 9 2010 1550 1559
8. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure New Engl J Med 336 8 1997 525 533
9. S. Lindsay, M. Kearney, R. Prescott, K. Fox, J. Nolan, and UK Heart Investigation Digoxin and mortality in chronic heart failure Lancet 354 9183 1999 1003
10. S. Rathore, Y. Wang, and H. Krumholz Sex based differences in the effect of digoxin for the treatment of heart failure New Engl J Med 347 18 2002 1403 1411
11. L. Friberg, N. Hammar, and M. Rosenqvist Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF) Heart 96 2010 275 280
12. S. Olsson on behalf of the SPORTIF III Investigators Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial Lancet 362 9397 2003 1691 1698
13. G. Albers, H. Diener, and L. Frison Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial JAMA 293 6 2005 690 698
14. P. Hallberg, J. Lindbäck, B. Lindahl, U. Stenestrand, H. Melhus RIKS-HIA Group Digoxin and mortality in atrial fibrillation: a prospective cohort study Eur J Clin Pharmacol 63 10 2007 959 971
15. G. Lip, and F. Hee Paroxysmal atrial fibrillation QJM-Int J Med 94 12 2001 665 678
16. F. Li-Saw-Hee, and G. Lip Digoxin revisited QJM-Int J Med 91 4 1998 259 264
17. F. Holmqvist, M. Stridh, J. Waktare, L. Sörnmo, S. Olsson, and C. Meurling Atrial fibrillation rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation Eur Heart J 27 18 2006 2201 2207
18. C. Elayi, M. Whitbeck, and R. Charnigo Is there an association between external cardioversions and long term mortality and morbidity - insights from the AFFIRM study Circ Arrhythm Electrophysiol April 21 2011 10.1161/CIRCEP.110. 960591 Published Online First
19. M. Packer, J. Carver, and R. Rodeheffer Effect of oral milrinone on mortality in severe heart failure New Engl J Med 325 21 1991 1468 1475
20. J. Parissis, P. Rafouli-Stergiou, V. Stasinos, P. Psarogiannakopoulos, and A. Mebazaa Inotropes in cardiac patients: update 2011 Curr Opin Crit Care 16 5 2010 432 441